Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.

Clinical trial NCT01898364 · COMPLETED

Trial details

NCT number: NCT01898364
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pompe Disease Glycogen Storage Disease Type II (GSD II)Acid Maltase Deficiency

Start date: 2013-08-19
Primary completion: 2015-02-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.